Sugammadex Injection, Solution
Product Images NDC 62756-079

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 62756-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sugammadex-carton-2ml (Spl Sugammadex Carton 2ml)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The label indicates 10 single-dose 2 mL vials and includes the Sun Pharmaceutical Industries, Inc. logo. It shows storage instructions, dosage notes, and manufacturer details for Recipharm in Germany. The label features the NDC 62756-079-02 and a barcode.*

FDA Label Image

Spl-sugammadex-carton-5ml (Spl Sugammadex Carton 5ml)

Box label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) sterile intravenous solution. The package contains 10 single-dose 5 mL vials. Distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Recipharm in Germany. Label includes storage instructions, product information, and barcode.*

FDA Label Image

Spl-sugammadex-figure 1 (Spl Sugammadex Figure 1)

A cumulative recovery rate graph comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over a 120-minute period. The x-axis shows time to recovery in minutes, and the y-axis displays cumulative recovery rate. Sugammadex shows rapid recovery near 1.0 early on, while neostigmine recovery is slower and more gradual. Median recovery times are indicated: 1.4 minutes for sugammadex and 21.5 minutes for neostigmine.*

FDA Label Image

Spl-sugammadex-figure 2 (Spl Sugammadex Figure 2)

A cumulative recovery rate graph comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg combined with vecuronium. The y-axis shows cumulative recovery rate, and the x-axis shows time to recovery in minutes, up to 120 minutes. Sugammadex shows a faster recovery with nearly all subjects recovering before 20 minutes, whereas neostigmine exhibits a slower recovery curve extending beyond 100 minutes. The graph includes median recovery times in a legend box.*

FDA Label Image

Spl-sugammadex-structure01 (Spl Sugammadex Structure01)

Chemical structure diagram of sugammadex showing the molecular arrangement with multiple sugar rings and functional groups, including sodium carboxylate moieties. The structure represents the active ingredient sugammadex used in injection, solution form.*

FDA Label Image

Spl-sugammadex-structure02 (Spl Sugammadex Structure02)

Chemical structure of sugammadex, showing a cyclic molecular arrangement with multiple sodium carboxylate groups and hydroxyl functionalities.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.